breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 32.9% | 179.7 / 132.3 | 143 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
* | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 25.4% | 295.5 / 104.3 | 130 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
* | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 25.4% | 244.6 / 110.1 | 139 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
* | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 23.6% | 261.6 / 70.7 | 127 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
* | NC_000913_3_bme_pgi | 83,587 | 0 | A | C | 22.9% | 207.5 / 68.5 | 105 | intergenic (‑58/+35) | leuA/leuL | 2‑isopropylmalate synthase/leu operon leader peptide |
* | NC_000913_3_bme_pgi | 83,590 | 0 | G | T | 22.3% | 249.5 / 59.1 | 103 | intergenic (‑61/+32) | leuA/leuL | 2‑isopropylmalate synthase/leu operon leader peptide |
Marginal new junction evidence (lowest skew 10 of 732 shown) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NC_000913_3_bme_pgi | = 3946688 | 93 (1.010) | 26 (0.300) | 21/244 | 6.3 | 22.7% | intergenic (+81/‑12) | rrlC/rrfC | 23S ribosomal RNA of rrnC operon/5S ribosomal RNA of rrnC operon |
? | NC_000913_3_bme_pgi | = 4171601 | NA (NA) | intergenic (+57/‑36) | rrlB/rrfB | 23S ribosomal RNA of rrnB operon/5S ribosomal RNA of rrnB operon | |||||
* | ? | NC_000913_3_bme_pgi | 2726200 = | NA (NA) | 26 (0.300) | 21/244 | 6.3 | NA | intergenic (‑12/+81) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon |
? | NC_000913_3_bme_pgi | 2726224 = | NA (NA) | intergenic (‑36/+57) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon | |||||
* | ? | NC_000913_3_bme_pgi | = 4171607 | 38 (0.410) | 24 (0.270) | 20/244 | 6.6 | 39.9% | intergenic (+63/‑30) | rrlB/rrfB | 23S ribosomal RNA of rrnB operon/5S ribosomal RNA of rrnB operon |
? | NC_000913_3_bme_pgi | = 4213022 | NA (NA) | intergenic (+76/‑18) | rrlE/rrfE | 23S ribosomal RNA of rrnE operon/5S ribosomal RNA of rrnE operon | |||||
* | ? | NC_000913_3_bme_pgi | = 228744 | 66 (0.710) | 24 (0.270) | 20/244 | 6.6 | 27.6% | intergenic (+82/‑12) | rrlH/rrfH | 23S ribosomal RNA of rrnH operon/5S ribosomal RNA of rrnH operon |
? | NC_000913_3_bme_pgi | 2726224 = | NA (NA) | intergenic (‑36/+57) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon | |||||
* | ? | NC_000913_3_bme_pgi | 360253 = | 88 (0.950) | 18 (0.210) | 16/234 | 7.5 | 18.8% | coding (262/1155 nt) | cynX | putative cyanate transporter |
? | NC_000913_3_bme_pgi | 360279 = | 75 (0.890) | coding (288/1155 nt) | cynX | putative cyanate transporter | |||||
* | ? | NC_000913_3_bme_pgi | 274329 = | NA (NA) | 21 (0.240) | 16/244 | 7.9 | NA | coding (789/1017 nt) | insH1 | IS5 transposase and trans‑activator |
? | NC_000913_3_bme_pgi | 274345 = | NA (NA) | coding (773/1017 nt) | insH1 | IS5 transposase and trans‑activator | |||||
* | ? | NC_000913_3_bme_pgi | 4326252 = | 129 (1.400) | 17 (0.190) | 15/242 | 8.2 | 12.2% | noncoding (450/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences |
? | NC_000913_3_bme_pgi | 4326282 = | 124 (1.420) | noncoding (480/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | |||||
* | ? | NC_000913_3_bme_pgi | 4326152 = | 116 (1.250) | 17 (0.190) | 15/242 | 8.2 | 12.7% | noncoding (350/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences |
? | NC_000913_3_bme_pgi | 4326282 = | 124 (1.420) | noncoding (480/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | |||||
* | ? | NC_000913_3_bme_pgi | 4325952 = | 117 (1.270) | 17 (0.190) | 15/242 | 8.2 | 12.7% | noncoding (150/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences |
? | NC_000913_3_bme_pgi | 4326282 = | 124 (1.420) | noncoding (480/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | |||||
* | ? | NC_000913_3_bme_pgi | 4325852 = | NA (NA) | 17 (0.190) | 15/242 | 8.2 | 12.1% | noncoding (50/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences |
? | NC_000913_3_bme_pgi | 4326282 = | 124 (1.420) | noncoding (480/583 nt) | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP325 (repetitive extragenic palindromic) element; contains 12 REP sequences |